Efficacy and Safety of LP-003 in Moderate-to-severe Seasonal Allergic Rhinitis Adult
Clinical trial NCT06046391 · COMPLETED
Trial details
- NCT number
- NCT06046391
- Sponsor
- Longbio Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-06
- Primary completion
- 2023-10-19
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.